Search research articles
Contact Us
Filters
Showing results (201-210 of 229) with videos related to
Page
of 23
Sort By:
Life Sciences
|
October 2, 2025
Retraction notice to "Silencing STAT3 enhances sensitivity of cancer cells to doxorubicin and inhibits tumor progression" [Life Sci. 275 (2021) 119369]
Navneet Joshi, Farnaz Hajizadeh, Ehsan Ansari Dezfouli, et al.
Reproductive Sciences (Thousand Oaks, Calif.)
|
September 26, 2022
Preeclampsia-Derived Exosomes Imbalance the Activity of Th17 and Treg in PBMCs from Healthy Pregnant Women
Ramin Pourakbari, Forough Parhizkar, Mohammad Sadegh Soltani-Zangbar, et al.
Life Sciences
|
March 22, 2021
Silencing STAT3 enhances sensitivity of cancer cells to doxorubicin and inhibits tumor progression
Navneet Joshi, Farnaz Hajizadeh, Ehsan Ansari Dezfouli, et al.
Cytokine
|
June 12, 2023
SARS-CoV2 infection induce miR-155 expression and skewed Th17/Treg balance by changing SOCS1 level: A clinical study
Mohammad Sadegh Soltani-Zangbar, Mahsa Hajivalili, Danyal Daneshdoust, et al.
International Journal of Biological Macromolecules
|
August 7, 2025
Retraction notice to "Blockade of CD73 using siRNA loaded chitosan lactate nanoparticles functionalized with TAT-hyaluronate enhances doxorubicin mediated cytotoxicity in cancer cells both in vitro and in vivo" [Int. J. Biol. Macromol. 186 (2021) 849-863]
Armin Mahmoud Salehi Khesht, Vahid Karpisheh, Parisa Sahami Gilan, et al.
International Journal of Biological Macromolecules
|
July 10, 2021
Blockade of CD73 using siRNA loaded chitosan lactate nanoparticles functionalized with TAT-hyaluronate enhances doxorubicin mediated cytotoxicity in cancer cells both in vitro and in vivo
Armin Mahmoud Salehi Khesht, Vahid Karpisheh, Parisa Sahami Gilan, et al.
Thrombosis Research
|
December 31, 2021
Tissue plasminogen activator for the treatment of adults with critical COVID-19: A pilot randomized clinical trial
Farid Rashidi, Stefano Barco, Parisa Rezaeifar, et al.
Cell Communication and Signaling : CCS
|
July 16, 2022
A comprehensive evaluation of the immune system response and type-I Interferon signaling pathway in hospitalized COVID-19 patients
Mohammad Sadegh Soltani-Zangbar, Forough Parhizkar, Elham Ghaedi, et al.
Molecular Biology Reports
|
September 1, 2022
Evaluation of CD39, CD73, HIF-1α, and their related miRNAs expression in decidua of preeclampsia cases compared to healthy pregnant women
Yousef Yousefzadeh, Mohammad Sadegh Soltani-Zangbar, Ladan Kalafi, et al.
Journal of Reproductive Immunology
|
April 4, 2021
A new approach to the preeclampsia puzzle; MicroRNA-326 in CD4<sup>+</sup> lymphocytes might be as a potential suspect
Mohammad Ali Zolfaghari, Roza Motavalli, Mohammad Sadegh Soltani-Zangbar, et al.
Page
of 23
Search research articles
Search
Showing results (201-210 of 229) with videos related to
Sort By:
Page
of 23
Life Sciences
|
October 2, 2025
Retraction notice to "Silencing STAT3 enhances sensitivity of cancer cells to doxorubicin and inhibits tumor progression" [Life Sci. 275 (2021) 119369]
Navneet Joshi, Farnaz Hajizadeh, Ehsan Ansari Dezfouli, et al.
Reproductive Sciences (Thousand Oaks, Calif.)
|
September 26, 2022
Preeclampsia-Derived Exosomes Imbalance the Activity of Th17 and Treg in PBMCs from Healthy Pregnant Women
Ramin Pourakbari, Forough Parhizkar, Mohammad Sadegh Soltani-Zangbar, et al.
Life Sciences
|
March 22, 2021
Silencing STAT3 enhances sensitivity of cancer cells to doxorubicin and inhibits tumor progression
Navneet Joshi, Farnaz Hajizadeh, Ehsan Ansari Dezfouli, et al.
Cytokine
|
June 12, 2023
SARS-CoV2 infection induce miR-155 expression and skewed Th17/Treg balance by changing SOCS1 level: A clinical study
Mohammad Sadegh Soltani-Zangbar, Mahsa Hajivalili, Danyal Daneshdoust, et al.
International Journal of Biological Macromolecules
|
August 7, 2025
Retraction notice to "Blockade of CD73 using siRNA loaded chitosan lactate nanoparticles functionalized with TAT-hyaluronate enhances doxorubicin mediated cytotoxicity in cancer cells both in vitro and in vivo" [Int. J. Biol. Macromol. 186 (2021) 849-863]
Armin Mahmoud Salehi Khesht, Vahid Karpisheh, Parisa Sahami Gilan, et al.
International Journal of Biological Macromolecules
|
July 10, 2021
Blockade of CD73 using siRNA loaded chitosan lactate nanoparticles functionalized with TAT-hyaluronate enhances doxorubicin mediated cytotoxicity in cancer cells both in vitro and in vivo
Armin Mahmoud Salehi Khesht, Vahid Karpisheh, Parisa Sahami Gilan, et al.
Thrombosis Research
|
December 31, 2021
Tissue plasminogen activator for the treatment of adults with critical COVID-19: A pilot randomized clinical trial
Farid Rashidi, Stefano Barco, Parisa Rezaeifar, et al.
Cell Communication and Signaling : CCS
|
July 16, 2022
A comprehensive evaluation of the immune system response and type-I Interferon signaling pathway in hospitalized COVID-19 patients
Mohammad Sadegh Soltani-Zangbar, Forough Parhizkar, Elham Ghaedi, et al.
Molecular Biology Reports
|
September 1, 2022
Evaluation of CD39, CD73, HIF-1α, and their related miRNAs expression in decidua of preeclampsia cases compared to healthy pregnant women
Yousef Yousefzadeh, Mohammad Sadegh Soltani-Zangbar, Ladan Kalafi, et al.
Journal of Reproductive Immunology
|
April 4, 2021
A new approach to the preeclampsia puzzle; MicroRNA-326 in CD4<sup>+</sup> lymphocytes might be as a potential suspect
Mohammad Ali Zolfaghari, Roza Motavalli, Mohammad Sadegh Soltani-Zangbar, et al.
Page
of 23